Diagnosis and management of meningococcal disease: the need for centralized care (Q36711470)

15 August 2017

1 reference

title

Diagnosis and management of meningococcal disease: the need for centralized care (English)

1 reference

15 August 2017

main subject

meningococcal disease

1 reference

Simon Nadel

1

1 reference

15 August 2017

J Simon Kroll

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

FEMS Microbiology Reviews

15 August 2017

published in

1 reference

15 August 2017

volume

31

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

71-83

1 reference

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Household crowding a major risk factor for epidemic meningococcal disease in Auckland children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Role of early fluid resuscitation in pediatric septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Optimising the investigation of meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Influenza A and meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Early treatment with parenteral penicillin in meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

The orthopaedic management of peripheral ischaemia in meningococcal septicaemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Clinical features of mild systemic meningococcal disease with characterization of bacterial isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Host genetic determinants of Neisseria meningitidis infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

The interactions between inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

A comparison of albumin and saline for fluid resuscitation in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Strategies to prevent neuronal damage in paediatric bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Adrenal insufficiency in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Non-traumatic coma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Prospective study of the treatment of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Steroid controversy in sepsis and septic shock: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Emergence of non-ceftriaxone-susceptible Neisseria meningitidis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Incidence of bacteremia in infants and children with fever and petechiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Features and outcome in meningococcal disease presenting with maculopapular rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Terlipressin as rescue therapy for intractable hypotension due to septic shock in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Lumbar puncture should not be performed in meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Emergency cranial computed tomography in the management of acute febrile encephalopathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Complement deficiencies in selected groups of patients with meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Pre-hospital parenteral antibiotic treatment of meningococcal disease and case fatality: a Danish population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Pathogenetic mechanisms of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Characterization of a myocardial depressant factor in meningococcal septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Pathophysiology of meningococcal meningitis and septicaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Cerebral herniation during bacterial meningitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Mortality in severe meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Steroids in adults with acute bacterial meningitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Update on meningococcal disease with emphasis on pathogenesis and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Mannitol for acute traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Outcome of Pre-hospital Antibiotic Treatment of Meningococcal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1574-6976.2006.00059.X

10.1111/J.1574-6976.2006.00059.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference